Lycia Therapeutics

0 followers

‌

We're building the leading extracellular protein degradation company leveraging our lysosomal targeting chimeras, or LYTAC, platform.

Industries

Headquarters

Stage

Employees

Links

Org chart

President & CEO

Aetna Wun Trombley

Collapse

Chief Scientific Officer

VP, Finance

Vice President, Nonclinical Development

Vice President, Intellectual Property

Executive Director, Head of Translational Medicine & Early Development

Head of Biologics

Associate Director, Project And Alliance Management

12 members

5 members

2 members

Motive

17 followers

Jack Morton Worldwide

3 followers

Secureworks

7 followers

Excellus BCBS

4 followers

Itron

12 followers

Discover companies